查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439489

全球陰道子宮托市場：洞察、競爭格局、市場預測：2030 年

Vaginal Pessary - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

2023年全球陰道托市場規模為2.9534億美元。預計到 2030 年，該市場將達到 5.1478 億美元，2024 年至 2030 年的預測期內複合年增長率為 9.76%。骨盆器官脫垂和壓力性尿失禁盛行率的上升以及容易發生骨盆器官脫垂的老年人口的增加將推動陰道子宮托市場的發展。此外，全球對非侵入性治療方案不斷增長的需求預計也將增強市場，並促進 2024-2030 年預測期內陰道子宮托市場的整體成長。

由於各種原因，陰道托市場的產品需求正在增加。骨盆器官脫垂和壓力性尿失禁盛行率的上升，以及容易發生骨盆器官脫垂和尿失禁的老年人口的增加，預計將推動全球陰道子宮托市場的發展。

例如，根據美國國家尿控協會 2019 年的數據，多達 4,000 萬名美國女性在一生中的某個階段經歷過膀胱滲漏問題。根據 2019 年的同一項研究，近一半的新手媽媽在正常分娩後經歷過失禁，大約六分之一的新手媽媽在剖腹產後經歷過失禁。此外，根據美國家庭醫師學會 2019 年引用的一項研究，尿失禁 (UI) 是一個常見問題，美國成年女性的盛行率為 51%。

此外，澳洲失禁基金會2022年提供的數據顯示，當年有超過500萬澳洲人（15歲以上人口中四分之一）出現膀胱或腸道控制問題，其中80%的尿失禁患者是女性。預計世界其他地區也會出現類似的趨勢。

該報告研究了全球陰道子宮托市場，並提供了市場概述，包括按類型、適應症、最終用途、地區和參與市場的公司概況劃分的趨勢。

目錄

第一章陰道子宮托市場報告簡介

第二章陰道子宮托市場執行摘要

第三章 監管分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第四章陰道托市場關鍵因素分析

  • 陰道托市場的驅動因素
  • 陰道托市場的限制與挑戰
  • 陰道子宮托市場機遇

第五章 陰道子宮托市場的波特五力分析

第六章 COVID-19 對陰道子宮托市場的影響分析

第七章 陰道子宮托市場概述

  • 按類型
  • 按指示
  • 按最終用途
  • 按地區

第八章陰道子宮托市場的全球公司份額分析 - 3至5家主要公司

第九章陰道子宮托市場公司與產品概況

  • CooperSurgical
  • MEDGYN PRODUCTS, INC.
  • Panpac Medical Corp.
  • Integra LifeSciences
  • Bliss GVS Pharma
  • Bioteque America Inc.
  • Personal Medical Corporation
  • Arabin GmbH & Co. KG
  • medesign I.C. GmbH
  • IndoSurgicals Private Limited.
  • Desco Medical India
  • Narang Medical Limited.
  • Bray Group Limited.
  • Digitimer Ltd
  • Thomas Medical.

第10章 KOL觀點

第十一章專案方法

第 12 章. 關於 DelveInsight

第十三章 免責聲明與聯絡我們

Product Code: DIMDCL0307

Vaginal Pessary Market By Type (Gellhorn, Ring, Donut, And Others), By Indication (Pelvic Organ Prolapse And Stress Urinary Incontinence), By End-Use (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of pelvic organ prolapse and stress urine incontinence and the rising number of geriatric population that are prone to pelvic organ prolapse

Global vaginal pessary market was valued at USD 295.34 million in 2023, growing at a CAGR of 9.76% during the forecast period from 2024 to 2030 to reach USD 514.78 million by 2030. The increasing prevalence of pelvic organ prolapse and stress urine incontinence and the rising number of geriatric population that are prone to pelvic organ prolapse will propel the market of the vaginal pessary. Moreover, the increasing demand of noninvasive treatment options across the world are also anticipated to bolster the market, thereby contributing to the growth of the overall vaginal pessary market during the forecast period from 2024-2030.

Vaginal Pessary Market Dynamics:

The vaginal pessary market is witnessing a growth in product demand owing to various reasons. The increasing prevalence of pelvic organ prolapse and stress urine incontinence and the rising number of geriatric population that are prone to pelvic organ prolapse and urinary incontinence across the world is expected to drive the vaginal pessary market.

For instance, For instance, according to the National Association for Continence 2019, up to 40 million women in America have experienced bladder leakage issues at some point in their lives. As per the same study in 2019, almost half of the new mothers experience incontinence following a normal delivery and about one in six following a cesarean section. Additionally, as per the study mentioned by the American Academy of Family Physicians in 2019, urinary incontinence (UI) is a common issue, with a prevalence of 51% among adult women in the United States.

Moreover, as per the data provided by the Continence Foundation of Australia in 2022, over 5 million Australians - 1 in 4 people aged 15 years or over - experienced bladder or bowel control problems in the same year, and 80% of people with urinary incontinence are women. Similar trends are likely to be observed in other regions of the world.

Also, it is observed that stress urinary incontinence is more common among women between the age of 41 and 55 and above. Thus, a rise in women aging population could also increase the risk of developing stress urinary incontinence, thereby bolstering the market. For instance, as per the World Population Ageing 2020 highlights published by the United Nations, women aged 65 years or over accounted for 55% of the total global population in 2020. Thus, the burgeoning cases of the diseases will contribute to the growth of the global vaginal pessary market in the upcoming years.

One of the prominent drivers of the vaginal pessary market is a surge in the aging population that is prone to urinary incontinence and weakening of the pelvic floor. For instance, according to the UN Report, World Population Ageing 2020 Highlights, globally, there were about 727 million people aged 65 years and above in 2020. Also, as per the same source, over the next three decades, the number of older people worldwide is projected to be more than double, reaching approximately 1.5 billion by 2050. Moreover, according to the United States Census Bureau 2022, more than 54 million adults above the age of 65 were living in the United States in the year 2023, accounting for about 16.5% of the United States population. As per the same source, the number of older adults living in the United States is large and growing; the total number of adults aged 65 years and older is projected to rise to an estimated number of 85.7 million by 2050, which accounts for about 20% of the overall population in the United States.

Furthermore, the number of people aged 65 years and over is expected to increase by 1.6% throughout 2022-2022 to a total of 12.7 million, accounting for about 18.9% of the total United Kingdom (UK) population. Moreover, according to the European Union 2020, in 2020, 28.7% of the population are 65 years and above in Japan. As per the same source, by 2036, people aged 65 and over will represent one-third of Japan's population.

Thus, the surge in the aging population will lead to the development of urinary incontinence, thereby leading to the weakening of the pelvic floor requiring treatment using vaginal pessaries are further contributing to the growth of the vaginal pessaries market during the forecast period from 2024 to 2030.

Thus, all the above mentioned factors will drive the market for vaginal pessary during the forecast period from 2024-2030.

However, the frequent replacement of the pessary which requires necessary visit to the doctor several times to have one fitted and some women cannot use it because of some other concerns such as women with lichen sclerosis cannot use pessaries to address their prolapse symptoms, women who had a hysterectomy and have prolapse have trouble keeping the pessary inside the body. These factors may hamper the market growth of the vaginal pessary.

The ongoing COVID-19 pandemic has slightly impacted the market for vaginal pessary. At the onset of the disease, there was a significant shortage, attributed to the imposition of stringent lockdowns to curb the spread of the virus. Hospital admissions for patients suffering from urological and other chronic disorders were not a priority in comparison to the patients suffering from coronavirus. Production of some medical devices was shut down. Furthermore, surgeries were temporarily stopped during the pandemic. To reduce the COVID-19 transmission risk, the physician have either postponed or canceled the semi-urgent and elective cases. However, with masses being vaccinated and with the return of resources and raw material, the vaginal pessary market has picked momentum.

Vaginal Pessary Market Segment Analysis:

Vaginal pessary Market by Type (Gellhorn, Ring, Donut, and Others), by Indication (Pelvic Organ Prolapse and Stress Urinary Incontinence), by End-Use (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the application type segment of the vaginal pessary market, the stress urinary incontinence is estimated to hold a significant share in the vaginal pessary market in the year 2023. This can be ascribed to the various application that is associated with this application.

For instance, according to the data published by the National Health Service (NHS), in 2022, between 3 and 6 million people in the UK might have some degree of urinary incontinence, with stress urinary incontinence being the most common of all types.

Moreover, the rising aging population in the United Kingdom is one of the risk factors for the developing stress urinary incontinence in the population. According to the United Nations Department of Economic and Social Affairs, Population Division, World Population Ageing 2019 Highlights, the prevalence of the population aged >=65 years in the United Kingdom in 2019 was 12,499,000. As per their estimates, the prevalence is projected to rise to 15,166,000 by 2030. Thus, the increasing prevalence of stress urinary incontinence will propel the market demand of vaginal pessary during the forecast period.

North America is expected to dominate the overall Vaginal Pessary Market:

Among all the regions, North America is expected to account for the significant share in the global vaginal pessary market.

Increasing prevalence of pelvic organ prolapse and stress urine incontinence and rising number of geriatric population that are prone to pelvic organ prolapse is expected to increase the demand for vaginal pessary in North America, leading to a rise in the overall vaginal pessary market growth. Furthermore, the increasing demand of noninvasive treatment options is also expected to drive the market growth.

For instance, as per the latest data available from Urology Care Foundation 2022, around one in three women suffer from stress urinary incontinence at some point in their lives, and it increases with age. Thus, the burgeoning cases of the diseases will contribute to the growth of the vaginal pessaries market in the region as the demand will increase.

Moreover, the rise in the population in the region who are susceptible to developing stress urinary incontinence is likely to increase the demand for these devices. The people at risk mainly include aging women, the population with weak pelvic muscles, obese people, and others. For instance, various studies have reported that obesity and overweight are directly associated with urinary incontinence and are independent risk factors for stress-related and mixed urinary incontinence. This is because obesity increases intra-abdominal pressures, which adversely stresses the pelvic floor and can contribute to urinary stress incontinence.

As per the Centers for Disease Control and Prevention (CDC) 2022, in the year 2020, the prevalence of obesity in the United States was 41.9%. As per the same source, it was calculated that through 2017 to March 2020, US obesity prevalence increased from 30.5% to 41.9%. During the same time, the prevalence of severe obesity increased from 4.7% to 9.2%. The increasing prevalence of obesity in the region may increase the risk of developing urinary incontinence which may further lead to the increased demand of the vaginal pessary. Therefore, increasing the overall market growth of the vaginal pessary in the North America in the year 2023 - 2028.

Thus, all the above-mentioned factors are anticipated to propel the North America vaginal pessary market growth.

Vaginal Pessary Market Key Players:

Some of the key market players operating in the vaginal pessary market include CooperSurgical, MEDGYN PRODUCTS, INC., Panpac Medical Corp., Integra LifeSciences, Bliss GVS Pharma, Bioteque America Inc., Personal Medical Corporation, Arabin GmbH & Co. KG, medesign I.C. GmbH, IndoSurgicals Private Limited., Desco Medical India, Narang Medical Limited., Bray Group Limited., Digitimer Ltd, Thomas Medical., among others.

Recent Developmental Activities in the Vaginal Pessary Market:

In March 2022, Indegene, a global enterprise healthtech solutions company and ConTIPI Medical Ltd, an innovator in the field of providing non-surgical and disposable solutions for women with various pelvic floor disfunctions, announced a partnership to bring a new device to the market to help women suffering from Pelvic Organ Prolapse (POP).

In November 2019, ConTIPI Medical, announced the development of a cutting edge non-surgical and disposable vaginal solutions for women with various Pelvic Floor Disorders. Within the vagina the devices open and provide support to predefined specific sites along vaginal walls. By the end of use, devices are removed by a pull of a string, which causes them to considerably diminish in size for disposal.

Key Takeaways from the Vaginal Pessary Market Report Study

  • Market size analysis for current vaginal pessary market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the vaginal pessary market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the global vaginal pessary market.
  • Various opportunities available for the other competitor in the vaginal pessary market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030.
  • Which is the top-performing regions and countries in the current vaginal pessary market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for vaginal pessary market growth in the coming future?

Target Audience who can be benefited from this Vaginal Pessary Market Report Study

  • Vaginal pessary products providers
  • Research organizations and consulting companies
  • Vaginal pessary-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in vaginal pessary
  • Various End-users who want to know more about the vaginal pessary market and latest technological developments in the vaginal pessary market.

Frequently Asked Questions for Vaginal Pessary Market:

1. What are vaginal pessary?

A vaginal pessary, is a medical device which is inserted into the vagina to support pelvic organs such as uterus, vagina, bladder, and rectum. The pessary are implanted to support sagging organs that have prolapsed or stopped urine flow.

2. What is the market for Global Vaginal pessary?

Global vaginal pessary market was valued at USD 295.34 million in 2023, growing at a CAGR of 9.76% during the forecast period from 2024 to 2030 to reach USD 514.78 million by 2030.

3. What are the drivers for the Global Vaginal pessary Market?

The vaginal pessary market is witnessing a positive market growth owing to the increasing prevalence of pelvic organ prolapse and stress urine incontinence and the rising number of geriatric population that are prone to pelvic organ prolapse. Additionally, the increasing demand of non-invasive treatment options across the world are anticipated to bolster the market.

4. Who are the key players operating in the Global Vaginal pessary Market?

Some of the key market players operating in the vaginal pessary market include Cooper Surgical, MEDGYN PRODUCTS, INC., Panpac Medical Corp., Integra LifeSciences, Bliss GVS Pharma, Bioteque America Inc., Personal Medical Corporation, Arabin GmbH & Co. KG, medesign I.C. GmbH, IndoSurgicals Private Limited., Desco Medical India, Narang Medical Limited., Bray Group Limited., Digitimer Ltd, Thomas Medical., others.

5. Which region has the highest share in vaginal pessary Market?

North America is expected to hold the highest share in the revenue in the vaginal pessary market during the forecast period. Increasing prevalence of pelvic organ prolapse and stress urine incontinence and rising number of geriatric population that are prone to pelvic organ prolapse will increase the demand for vaginal pessary in North America.

Table of Contents

1.Vaginal pessary Market Report Introduction

2.Vaginal pessary Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Vaginal pessary Market Key Factors Analysis

  • 4.1. Vaginal pessary Market Drivers
    • 4.1.1. Increasing prevalence of pelvic organ prolapse and stress urine incontinence
    • 4.1.2. Rising number of geriatric population that are prone to pelvic organ prolapse
    • 4.1.3. Increasing demand of noninvasive treatment options
  • 4.2. Vaginal pessary Market Restraints and Challenges
    • 4.2.1. Should be replaced frequently
    • 4.2.2. Not suitable for all women
  • 4.3. Vaginal pessary Market Opportunities
    • 4.3.1. Utilization of 3D printing technology
    • 4.3.2. Development of customized implants and painless implantation procedure

5. Vaginal pessary Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Vaginal pessary Market

7. Vaginal pessary Market Layout

  • 7.1. By Type
    • 7.1.1. Gellhorn
    • 7.1.2. Ring
    • 7.1.3. Donut
    • 7.1.4. Others
  • 7.2. By Indication
    • 7.2.1. Pelvic Organ Prolapse
    • 7.2.2. Stress Urinary Incontinence
  • 7.3. By End-use
    • 7.3.1. Hospitals & Clinics
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States
      • 7.4.1.2. Canada
      • 7.4.1.3. Mexico
    • 7.4.2. Europe
      • 7.4.2.1. France
      • 7.4.2.2. Germany
      • 7.4.2.3. United Kingdom
      • 7.4.2.4. Italy
      • 7.4.2.5. Spain
      • 7.4.2.6. Russia
      • 7.4.2.7. Rest of Europe
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China
      • 7.4.3.2. Japan
      • 7.4.3.3. India
      • 7.4.3.4. Australia
      • 7.4.3.5. South Korea
      • 7.4.3.6. Rest of Asia Pacific
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East
      • 7.4.4.2. Africa
      • 7.4.4.3. South America

8. Vaginal pessary Market Global Company Share Analysis - Key 3-5 Companies

9. Vaginal pessary Market Company and Product Profiles

  • 9.1. CooperSurgical
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. MEDGYN PRODUCTS, INC.
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Panpac Medical Corp.
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Integra LifeSciences
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Bliss GVS Pharma
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Bioteque America Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Personal Medical Corporation
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Arabin GmbH & Co. KG
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. medesign I.C. GmbH
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. IndoSurgicals Private Limited.
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Desco Medical India
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Narang Medical Limited.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Bray Group Limited.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Digitimer Ltd
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Thomas Medical.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Vaginal pessary Market in Global (2021-2030)
  • Table 4: Vaginal pessary Market in Global by Type (2021-2030)
  • Table 5: Vaginal pessary Market in Global by Indication (2021-2030)
  • Table 6: Vaginal pessary Market in Global by End User (2021-2030)
  • Table 7: Vaginal pessary Market in Global by Geography (2021-2030)
  • Table 8: Vaginal pessary Market in North America (2021-2030)
  • Table 9: Vaginal pessary Market in North America by Country (2021-2030)
  • Table 10: Vaginal pessary Market in the US (2021-2030)
  • Table 11: Vaginal pessary Market in Canada (2021-2030)
  • Table 12: Vaginal pessary Market in Mexico (2021-2030)
  • Table 13: Vaginal pessary Market in Europe (2021-2030)
  • Table 14: Vaginal pessary Market in Europe by Country (2021-2030)
  • Table 15: Vaginal pessary Market in France (2021-2030)
  • Table 16: Vaginal pessary Market in Germany (2021-2030)
  • Table 17: Vaginal pessary Market in the United Kingdom (2021-2030)
  • Table 18: Vaginal pessary Market in Italy (2021-2030)
  • Table 19: Vaginal pessary Market in Spain (2021-2030)
  • Table 20: Vaginal pessary Market in Russia (2021-2030)
  • Table 21: Vaginal pessary Market in Rest of Europe (2021-2030)
  • Table 22: Vaginal pessary Market in APAC (2021-2030)
  • Table 23: Vaginal pessary Market in APAC by Country (2021-2030)
  • Table 24: Vaginal pessary Market in China (2021-2030)
  • Table 25: Vaginal pessary Market in Japan (2021-2030)
  • Table 26: Vaginal pessary Market in India (2021-2030)
  • Table 27: Vaginal pessary Market in Australia (2021-2030)
  • Table 28: Vaginal pessary Market in South Korea (2021-2030)
  • Table 29: Vaginal pessary Market in Rest of APAC (2021-2030)
  • Table 30: Vaginal pessary Market in Rest of World (2021-2030)
  • Table 31: Vaginal pessary Market in RoW by Region (2021-2030)
  • Table 32: Vaginal pessary Market in Middle East (2021-2030)
  • Table 33: Vaginal pessary Market in Africa (2021-2030)
  • Table 34: Vaginal pessary Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Vaginal pessary Market in Global (2021-2030)
  • Figure 4: Vaginal pessary Market in Global by Type (2021-2030)
  • Figure 5: Vaginal pessary Market in Global by Indication (2021-2030)
  • Figure 6: Vaginal pessary Market in Global by End User (2021-2030)
  • Figure 7: Vaginal pessary Market in Global by Geography (2021-2030)
  • Figure 8: Vaginal pessary Market in North America (2021-2030)
  • Figure 9: Vaginal pessary Market in North America by Country (2021-2030)
  • Figure 10: Vaginal pessary Market in the US (2021-2030)
  • Figure 11: Vaginal pessary Market in Canada (2021-2030)
  • Figure 12: Vaginal pessary Market in Mexico (2021-2030)
  • Figure 13: Vaginal pessary Market in Europe (2021-2030)
  • Figure 14: Vaginal pessary Market in Europe by Country (2021-2030)
  • Figure 15: Vaginal pessary Market in France (2021-2030)
  • Figure 16: Vaginal pessary Market in Germany (2021-2030)
  • Figure 17: Vaginal pessary Market in the United Kingdom (2021-2030)
  • Figure 18: Vaginal pessary Market in Italy (2021-2030)
  • Figure 19: Vaginal pessary Market in Spain (2021-2030)
  • Figure 20: Vaginal pessary Market in Russia (2021-2030)
  • Figure 21: Vaginal pessary Market in Rest of Europe (2021-2030)
  • Figure 22: Vaginal pessary Market in APAC (2021-2030)
  • Figure 23: Vaginal pessary Market in APAC by Country (2021-2030)
  • Figure 24: Vaginal pessary Market in China (2021-2030)
  • Figure 25: Vaginal pessary Market in Japan (2021-2030)
  • Figure 26: Vaginal pessary Market in India (2021-2030)
  • Figure 27: Vaginal pessary Market in Australia (2021-2030)
  • Figure 28: Vaginal pessary Market in South Korea (2021-2030)
  • Figure 29: Vaginal pessary Market in Rest of APAC (2021-2030)
  • Figure 30: Vaginal pessary Market in Rest of World (2021-2030)
  • Figure 31: Vaginal pessary Market in RoW by Region (2021-2030)
  • Figure 32: Vaginal pessary Market in Middle East (2021-2030)
  • Figure 33: Vaginal pessary Market in Africa (2021-2030)
  • Figure 34: Vaginal pessary Market in South America (2021-2030)
  • Figure 35: Market Drivers
  • Figure 36: Market Barriers
  • Figure 37: Marker Opportunities
  • Figure 38: PORTER'S Five Force Analysis